When we performed a multivariate analysis (variable introduced in the model: shock at admission, acute renal failure and 2007 IDSA/ATS agreement) the association was still significantly present (OR 0.39, 95%% CI 0.17 0.91).
In multivariate analysis performed by introducing all the above variables in the Cox proportional hazards model, lymph node status, pEGFR and pErbB4 retained independent prognostic significance (Table 3, Figure 3).
However, in multivariate analysis performed by introducing all the above variables in the Cox proportional hazards model, lymph node status, pErbB3 and pErbB4 expression retained independent prognostic significance (Table 2).> Survival analysis was performed on 155 stage I-lV patients for overall survival.
For this purpose, multivariate analysis was carried out, introducing adenocarcinoma as a covariable.
Any variables reaching P=0.05 were introduced in multivariate analysis.
Other variables were introduced in multivariate analysis if P < 0.15 in univariate analysis.
The variables with p values < 0.1 were introduced in multivariate analysis and, after that, those with p values <0.05 were considered as independently associated with viral RNA detection.
Future papers in the series cover multivariate analysis and the last paper introduces some more advanced concepts in a brief question and answer format.
The clinical variables such as age, headache frequency and duration, allodynia, SAS, SDS, MAF, MIDAS, SLP9, MOS, and TTS, were introduced in a multivariate analysis (MANOVA) with type III sum of square where the comorbidity for FM was the main factor.
When introduced in the multivariate analysis instead of seasonal influenza immunization behavior, the level of compliance with vaccination remained significant in the final model (OR = 3.15; 95% CI: 2.39 to 4.15).
